一项关于复发/难治性霍奇金淋巴瘤的间断和持续剂量雷那替尼的II期研究。
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma.
发表日期：2023 Sep 14
作者：
Todd A Fehniger, Marcus P Watkins, Nkiruka Ezenwajiaku, Fei Wan, David D Hurd, Amanda F Cashen, Kristie A Blum, Andre Goy, Timothy S Fenske, Nina D Wagner-Johnston, Kenneth Carson, Marilyn J Siegel, David Russler-Germain, Stephanie E Schneider, Neha Mehta-Shah, Brad Kahl, Nancy L Bartlett
来源：
HAEMATOLOGICA
摘要：
暂无。
Not available.